Stock Track | ALI HEALTH Plummets 5.10% Intraday After Goldman Sachs Cuts Target Price on AI and Drug Investment Concerns

Stock Track

04/09

ALI HEALTH's stock plummeted 5.10% during intraday trading on Thursday, reflecting significant selling pressure.

The decline followed a report from Goldman Sachs which lowered its target price for ALI HEALTH from HK$5.20 to HK$4.80 while maintaining a "Neutral" rating. The adjustment reflects the bank's concerns that increased investments in artificial intelligence (AI) and pharmaceutical categories will negatively impact the company's profitability in the near term.

Goldman Sachs anticipates a slight profit contraction in the second half of the year, reversing the profit expansion seen in the first half. This outlook is primarily attributed to higher spending on AI initiatives and increased discounts on proprietary drugs offered in response to competitive pressures within the market.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1141985297"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1141985297\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1141985297?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-09 15:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1141985297","market":"hk","top_or_hot":-1,"title":"Stock Track | ALI HEALTH Plummets 5.10% Intraday After Goldman Sachs Cuts Target Price on AI and Drug Investment Concerns","media":"Stock Track","content":"<p>ALI HEALTH's stock plummeted 5.10% during intraday trading on Thursday, reflecting significant selling pressure.</p><p>The decline followed a report from Goldman Sachs which lowered its target price for ALI HEALTH from HK$5.20 to HK$4.80 while maintaining a \"Neutral\" rating. The adjustment reflects the bank's concerns that increased investments in artificial intelligence (AI) and pharmaceutical categories will negatively impact the company's profitability in the near term.</p><p>Goldman Sachs anticipates a slight profit contraction in the second half of the year, reversing the profit expansion seen in the first half. This outlook is primarily attributed to higher spending on AI initiatives and increased discounts on proprietary drugs offered in response to competitive pressures within the market.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | ALI HEALTH Plummets 5.10% Intraday After Goldman Sachs Cuts Target Price on AI and Drug Investment Concerns</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | ALI HEALTH Plummets 5.10% Intraday After Goldman Sachs Cuts Target Price on AI and Drug Investment Concerns\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2026-04-09 15:53</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>ALI HEALTH's stock plummeted 5.10% during intraday trading on Thursday, reflecting significant selling pressure.</p><p>The decline followed a report from Goldman Sachs which lowered its target price for ALI HEALTH from HK$5.20 to HK$4.80 while maintaining a \"Neutral\" rating. The adjustment reflects the bank's concerns that increased investments in artificial intelligence (AI) and pharmaceutical categories will negatively impact the company's profitability in the near term.</p><p>Goldman Sachs anticipates a slight profit contraction in the second half of the year, reversing the profit expansion seen in the first half. This outlook is primarily attributed to higher spending on AI initiatives and increased discounts on proprietary drugs offered in response to competitive pressures within the market.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00241","symbol_name":"阿里健康","start_time":0,"source_url":"","article_id":"1141985297","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1141985297","pubTimestamp":1775721208,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"ALI HEALTH's stock plummeted 5.10% during intraday trading on Thursday, reflecting significant selling pressure.The decline followed a report from Goldman Sachs which lowered its target price for ALI...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00241":"阿里健康"},"translate_title":"个股赛道|阿里健康盘中暴跌5.10%高盛因AI和药物投资担忧下调目标价","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00241":1},"content_text":"ALI HEALTH's stock plummeted 5.10% during intraday trading on Thursday, reflecting significant selling pressure.The decline followed a report from Goldman Sachs which lowered its target price for ALI HEALTH from HK$5.20 to HK$4.80 while maintaining a \"Neutral\" rating. The adjustment reflects the bank's concerns that increased investments in artificial intelligence (AI) and pharmaceutical categories will negatively impact the company's profitability in the near term.Goldman Sachs anticipates a slight profit contraction in the second half of the year, reversing the profit expansion seen in the first half. This outlook is primarily attributed to higher spending on AI initiatives and increased discounts on proprietary drugs offered in response to competitive pressures within the market.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}